87 reports

Ltd. ##. ## NuGEN Technologies, Inc. ##. ## Takara Bio, Inc. ##. ## F Hoffmann-La Roche Ltd. ##. ## Oxford Nanopore Technologies ##. ## Fludigim ##. ## Agilent Technologies Inc ## Appendix ## Disclaimer List of Tables Table ## Global Single-Cell Genome Sequencing Market Analysis,

  • Genome Sequencing
  • Genomics
  • World
  • Market Size

## Sample Preparation Requirements for International Customers TABLE ## Estimated new female cases of breast cancer & deaths in US, 2017 TABLE ## North America single-cell genome sequencing market, by product 2014 - 2025 (USD Million) TABLE ## North America single-cell

  • Genome Sequencing
  • Genomics
  • United States
  • Demand
  • Market Size
  • 7.7 WHOLE-GENOME SEQUENCING
  • HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL

“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%” The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing,...

  • Genome Sequencing
  • North America
  • United States
  • World
  • QIAGEN N.V.
  • GENOME SEQUENCING
  • GLOBAL GENOME SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

In our study, we have segmented the next generation sequencing market by product, service, application and end-users.The products considered in the study are platform, services, and consumables. The platform segment is further segmented as Hiseq, Miseq, Solid, ION Torrent, Pacbio Rs II & Sequel Systems.The sub-segment of services is...

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.
  • GENOME SEQUENCING
  • APRIL 2015

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic...

  • Genome Sequencing
  • North America
  • United States
  • Market Size
  • Illumina, Inc.
  • 7.5 WHOLE GENOME SEQUENCING
  • Whole Genome Sequencing

The global microbiome sequencing services market is poised to reach USD 1424.7 million by 2021 from USD 538.0 million in 2016, at a CAGR of 21.5% from 2016 to 2021. The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving...

  • Genome Sequencing
  • Genomics
  • World
  • Market Size
  • Zymo Research Corporation
  • Global Next Generation Sequencing Services Market in Genome Sequencing, 2015 -
  • Global Next Generation Sequencing Services Market Share, by Key Players 2016 & 2021

According to the new report “Global Next Generation Sequencing Market Assessment & Forecast: 2017 - 2021” by SA-Business Research & Consulting Group, Illumina leads the market with more than 75% market share. The global next generation sequencing market was valued at US$ 3,509.6 Million in 2016 and is expected to reach US$ 7,527.0 Million...

  • Genome Sequencing
  • World
  • Illumina, Inc.
  • Oxford Nanopore Technologies Limited
  • QIAGEN N.V.
  • JUL 13, 2017: WORLD-LEADING CANCER RESEARCHERS FIRST IN UK TO RECEIVE NOVASEQ - THE LATEST GENOME SEQUENCING TECHNOLOGY
  • JUL 13, 2017: WORLD-LEADING CANCER RESEARCHERS FIRST IN UK TO RECEIVE NOVASEQ - THE LATEST GENOME SEQUENCING TECHNOLOGY

Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents;...

  • Genome Sequencing
  • Molecular Diagnostic
  • United States
  • Company
  • Illumina, Inc.
  • 5.1.1.1 WHOLE GENOME SEQUENCING
  • Next-generation Sequencing Market: Revenue in USD million, by Sequencing Type,

Next Generation Sequencing (NGS) Market The Global Next Generation Sequencing Market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. Next generation sequencing, also known as high-throughput sequencing, is a DNA sequencing technology that has revolutionized genomic research. Due to its ability...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Roche Group

Genome sequencing/ mapping

  • DNA Sequencing
  • Genome Sequencing
  • Genomics
  • World
  • 5.5 WHOLE GENOME SEQUENCING
  • WHOLE GENOME SEQUENCING SAMPLES MARKET

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was...

  • Genome Sequencing
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.

Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022 ##.

  • Genome Sequencing
  • Genomics
  • World
  • Market Shares
  • 12.7.4.1 Product/Service Launches and Approvals
  • 12.12 MACROGEN, INC.

The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Illumina, Inc.
  • Vendor classification
  • Identifying factors impacting market growth

About Prenatal DNA Sequencing Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer. Technavio’s analysts forecast...

  • Genome Sequencing
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.
  • DURING THE FORECAST PERIOD
  • GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION)

The global gene panels market projected to grow at a CAGR of 19.2%. The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Thermo Fisher Scientific, Inc.

Global Microbiome Sequencing Services Market Analysis 2017 - Forecast to 2025 ## Introduction ##. ## Scope of the Report ##. ## Report Description ##. ## Research Methodology ##. ## Research Sources ##. ##. ## Secondary Research ##. ##. ## Primary Research ##. ##. ## Assumptions ##. ## List of Abbreviations ## Ex

  • Genome Sequencing
  • APAC
  • Europe
  • Middle East
  • World
  • Sep 04, 2017: Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe
  • Jan 11, 2016: Macrogen Deploys Multiple DRAGEN Processors from Edico Genome to Speed its Large-Scale Genome Analysis and Clinical Sequencing Service

Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats....

  • Genome Sequencing
  • Genomics
  • World
  • Company Financials
  • Macrogen, Inc.

The TOPMed program colects whole-genome sequencing and other -omics data.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • WUXI GENOME CENTER PURCHASES ILLUMINA'S GENOME SEQUENCING SYSTEM
  • ILLUMINA, INC.: CORPORATE GOVERNANCE

Summary Illumina, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company. Key Findings - Detailed...

  • Genome Sequencing
  • Genomics
  • United States
  • Company
  • Illumina, Inc.
  • April 2015
  • HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic...

  • Genome Sequencing
  • North America
  • United States
  • Market Size
  • Illumina, Inc.
  • Indication
  • ILLUMINA INC PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW

Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents;...

  • Genome Sequencing
  • United States
  • Company
  • Company Financials
  • Illumina, Inc.
  • Jul 03, 2017: Human Longevity Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology
  • ASSET PURCHASE

Summary Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data.Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and companion diagnostics. HLI...

  • Genome Sequencing
  • Therapy
  • United States
  • Company
  • Celgene Corporation
  • 7.1 BY TECHNOLOGY
  • 5.1 BY TECHNOLOGY

In March 2014, Human Longevity Inc. announced that it would build the world' s largest human genome sequencing center, with the capacity of sequencing up to ##, ## human genomes per year.

  • Genome Sequencing
  • North America
  • United States
  • World
  • QIAGEN N.V.
  • Feb 14, 2017: Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on PacBio Sequencing Platforms
  • SWIFT BIOSCIENCES RAISES US$0.5 MILLION IN VENTURE FINANCING

Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools.The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA library kit, comprehensive...

  • Genome Sequencing
  • Genomics
  • Molecular Diagnostic
  • United States
  • Company
  • 6.6 BIOINFORMATICS TOOLS
  • GLOBAL BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)

In addition, sequencing the human genome requires massive computational and storage capabilities.

  • Genome Sequencing
  • North America
  • United States
  • World
  • Thermo Fisher Scientific, Inc.
  • HAMILTON ROBOTICS PARTNERS WITH ILLUMINA
  • This agreement enables Analytik Jena and Illumina to provide solutions for ultra-high throughput genotyping.

United States Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, United States Genetic Testing Market Outlook to 2024, provides key market data on the United States Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired...

  • Diagnostics
  • Genetic
  • Genome Sequencing
  • Hospital
  • Thermo Fisher Scientific, Inc.

Next Generation Sequencing - Global Market Outlook (2016-2022) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Pr

  • Genome Sequencing
  • APAC
  • Europe
  • World
  • Market Size
  • 13.8 ILLUMINA, INC.

The company' s research software, HLA Explore analyzes data from any sequencing technology and determines HLA genotypes from Whole Exome/ Genome Sequencing experiments.

  • Genome Sequencing
  • Prosthesis
  • North America
  • United States
  • Market Size
  • TAKARA BIO ACQUIRES RUBICON GENOMICS FOR USD75 MILLION
  • VENTURE FINANCING

The technology is currently available for sequencing on Illumina HiSeq, MiSeq and Genome Analyzer instruments.

  • Genome Sequencing
  • Genomics
  • United States
  • Company
  • Takara Bio Inc.
  • 9.2 ILLUMINA INC

NextSeq series MiSeq series Description HiSeq X five series The HiSeq X Five System enables fast and affordable human whole-genome sequencing on a massive scale.

  • Genome Sequencing
  • North America
  • United States
  • World
  • Market Size